Pion Showcases How to Achieve In-Vivo Level Insights Via In-Vitro Solutions at AAPS PharmSci 360 2022

September 30, 2022
min read

Billerica MA - September 30 2022: Pion Inc, a leading provider of innovative analytical solutions for drug development, will be exhibiting on booth 1337 at this year's AAPS conference. We will be showcasing how our innovative instruments assist formulation scientists by providing richer, more relevant insights on dissolution, solubility, ionization and much more not easily accessible prior to clinical studies.

Pion’s analytical instruments bridge the gap between in vitro experiments and in vivo outcomes. They enable companies to confidently decide which drug substances and drug products to progress through the development pipeline while reducing risk and long-term investment.

The company is presenting six posters at the conference covering a range of topics including subcutaneous formulation development, concentration monitoring in dissolution studies, food-effect risk monitoring in pre-formulation and more. Visit our website to get full details of the topics, location and times of the poster sessions.

During the conference, Pion will be previewing a new product that will expand the power of its SCISSOR N3 (subcutaneous site injection simulator) on booth. Stop by to find out more and to register for the launch webinar on October 20th.

‘Pion is committed to delivering exceptional in vitro tools that effectively mimic in vivo behavior,’ said  Brian Dutko, CEO of Pion. ‘We look forward to showing you, at AAPS PharmSci 360, how you can make better decisions earlier during formulation development, to bring clinically effective products to market faster.’